menu
    • menu

    Company profile for Dewpoint Therapeutics

    NEW Drugs in Dev: 2
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a dynamic young biotech company based in Boston and Dresden that is translating brand-new insights about biomolecular condensates into treatments for the toughest diseases. Dewpoint strives to cultivate an inclusive international community that welcomes and empowers everyone. We reject racism, discrimination, harassment, brutality, and all other manifestations of hate. Dewpoint Therapeutics is the first company founded ...
    We are a dynamic young biotech company based in Boston and Dresden that is translating brand-new insights about biomolecular condensates into treatments for the toughest diseases. Dewpoint strives to cultivate an inclusive international community that welcomes and empowers everyone. We reject racism, discrimination, harassment, brutality, and all other manifestations of hate. Dewpoint Therapeutics is the first company founded to apply the emerging discipline of biomolecular condensates to drug discovery. Dewpoint believes that a vast range of conditions have pathways that are regulated by condensates.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Dewpoint TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    6 Tide Street, Suite 300 Boston, MA 02210
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://dewpointx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/dewpointtherapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PCHi

    PCHi

    Not Confirmed

    envelop Contact Supplier

    PCHi

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Dewpoint Selects First-in-Class MYC Modulator Lead Candidate
    Dewpoint Selects First-in-Class MYC Modulator Lead Candidate

    11 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/11/3236428/0/en/Dewpoint-Therapeutics-Selects-First-in-Class-MYC-Condensate-Modulator-Development-Candidate.html

    GLOBENEWSWIRE
    11 Feb 2026
    Share Share
    Dewpoint Doses First Patient in DPTX3186 Trial of Advance Tumors
    Dewpoint Doses First Patient in DPTX3186 Trial of Advance Tumors

    04 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/04/3232220/0/en/Dewpoint-Therapeutics-Doses-First-Patient-in-Phase-1a-2a-Trial-DPTX3186-for-the-Treatment-of-Advanced-Solid-Tumors-Focused-on-Gastric-Cancer.html

    GLOBENEWSWIRE
    04 Feb 2026
    Share Share
    Dewpoint Therapeutics Unveils ALS Treatment Candidate For TDP-43
    Dewpoint Therapeutics Unveils ALS Treatment Candidate For TDP-43

    08 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/08/3215515/0/en/Dewpoint-Therapeutics-Announces-TDP-43-Condensate-Modulator-Development-Candidate-for-Treatment-of-ALS-and-Related-Neurodegenerative-Diseases.html

    GLOBENEWSWIRE
    08 Jan 2026
    Share Share
    Dewpoint Pharma Initiates Viral Condensate Phenomics Atlas
    Dewpoint Pharma Initiates Viral Condensate Phenomics Atlas

    06 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/06/3213799/0/en/Dewpoint-Therapeutics-Launches-Initiative-to-Build-Viral-Condensate-Phenomics-Atlas-for-HPV.html

    GLOBENEWSWIRE
    06 Jan 2026
    Share Share
    FDA Fast-Tracks Dewpoint's DPTX3186 to Treat Gastric Cancer
    FDA Fast-Tracks Dewpoint's DPTX3186 to Treat Gastric Cancer

    17 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/17/3189301/0/en/FDA-Grants-Fast-Track-Designation-to-Dewpoint-Therapeutics-DPTX3186-for-the-Treatment-of-Gastric-Cancer.html

    GLOBENEWSWIRE
    17 Nov 2025
    Share Share
    FDA Grants Orphan Drug Designation to Dewpoint’ DPTX3186
    FDA Grants Orphan Drug Designation to Dewpoint’ DPTX3186

    29 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/29/3176579/0/en/FDA-Grants-Orphan-Drug-Designation-to-Dewpoint-Therapeutics-DPTX3186-for-the-Treatment-of-Gastric-Cancer.html

    GLOBENEWSWIRE
    29 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search